Cytokinetics Inc (CYTK) financials · rev $88.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cytokinetics Inc (CYTK) rev $88.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $88.0M | $18.5M |
| Operating Income | -$612.3M | -$536.2M |
| Net Income | -$785.0M | -$589.5M |
| EPS (Diluted) | -$6.54 | -$5.26 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.42B | $1.40B |
| Current Assets | $917.0M | $1.11B |
| Cash & Equivalents | $122.5M | $94.9M |
| Inventory | $0 | N/A |
| PP&E | $79.2M | $65.8M |
| Total Liabilities | $2.08B | $1.54B |
| Current Liabilities | $202.5M | $179.7M |
| Short-term Debt | $41.2M | $11.5M |
| Long-term Debt | $246.4M | $93.2M |
| Total Debt | $287.6M† | $104.7M† |
| Shareholders' Equity | -$659.6M | -$135.4M |
| Retained Earnings | -$3.49B | -$2.70B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$510.0M | -$395.9M |
| CapEx | $24.8M | $3.91M |
| Investing Cash Flow | $16.7M | -$553.1M |
| Financing Cash Flow | $524.5M | $930.6M |
| Net Change in Cash | $30.4M | -$18.2M |
| Free Cash Flow | -$534.8M | -$399.8M |
FAQ
What is CYTK P/E and revenue?
Cytokinetics Inc (CYTK) rev $88.0M.
What is CYTK revenue?
Cytokinetics Inc last cached revenue is $88.0M (FY2025).
Is CYTK profitable?
Cytokinetics Inc last cached net income is -$785.0M (FY2025).
What are CYTK total assets?
Cytokinetics Inc last cached total assets are $1.42B (FY2025).
What is CYTK free cash flow?
Cytokinetics Inc last cached free cash flow is -$534.8M (FY2025).
Not investment advice. Cached statements, not a live tape.